Zobrazeno 1 - 10
of 103
pro vyhledávání: '"de Langen, AJ"'
Publikováno v:
OncoTargets and Therapy, Vol Volume 10, Pp 4535-4541 (2017)
Ittai B Muller,1 Adrianus J de Langen,2,3 Elisa Giovannetti,4,5 Godefridus J Peters4 1Department of Clinical Chemistry, 2Department of Pulmonology, VU University Medical Center, 3Department of Thoracic Oncology, Netherlands Cancer Institute, 4Departm
Externí odkaz:
https://doaj.org/article/30fbc900c360466e8620d78c38529795
Autor:
Kramer, GM, Liu, Y, De Langen, AJ, Jansma, EP, Trigonis, I, Asselin, M-C, Jackson, A, Kenny, L, Aboagye, EO, Hoekstra, OS, Boellaard, R, QuIC-ConCePT consortium
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging, 45(6), 951-961. Springer Verlag
Kramer, G M, Liu, Y, de Langen, A J, Jansma, E P, Trigonis, I, Asselin, M-C, Jackson, A, Kenny, L, Aboagye, E O, Hoekstra, O S & Boellaard, R 2018, ' Repeatability of quantitative 18F-FLT uptake measurements in solid tumors: an individual patient data multi-center meta-analysis ', European Journal of Nuclear Medicine and Molecular Imaging . https://doi.org/10.1007/s00259-017-3923-x
Kramer, G M, Liu, Y, de Langen, A J, Jansma, E P, Trigonis, I, Asselin, M C, Jackson, A, Kenny, L, Aboagye, E O, Hoekstra, O S, Boellaard, R & on behalf of the QuIC-ConCePT Consortium 2018, ' Repeatability of quantitative 18 F-FLT uptake measurements in solid tumors : an individual patient data multi-center meta-analysis ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 45, no. 6, pp. 951-961 . https://doi.org/10.1007/s00259-017-3923-x
European Journal of Nuclear Medicine and Molecular Imaging
Kramer, G M, Liu, Y, de Langen, A J, Jansma, E P, Trigonis, I, Asselin, M-C, Jackson, A, Kenny, L, Aboagye, E O, Hoekstra, O S & Boellaard, R 2018, ' Repeatability of quantitative 18F-FLT uptake measurements in solid tumors: an individual patient data multi-center meta-analysis ', European Journal of Nuclear Medicine and Molecular Imaging . https://doi.org/10.1007/s00259-017-3923-x
Kramer, G M, Liu, Y, de Langen, A J, Jansma, E P, Trigonis, I, Asselin, M C, Jackson, A, Kenny, L, Aboagye, E O, Hoekstra, O S, Boellaard, R & on behalf of the QuIC-ConCePT Consortium 2018, ' Repeatability of quantitative 18 F-FLT uptake measurements in solid tumors : an individual patient data multi-center meta-analysis ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 45, no. 6, pp. 951-961 . https://doi.org/10.1007/s00259-017-3923-x
European Journal of Nuclear Medicine and Molecular Imaging
Introduction 3′-deoxy-3′-[18F]fluorothymidine (18F–FLT) positron emission tomography (PET) provides a non-invasive method to assess cellular proliferation and response to antitumor therapy. Quantitative 18F–FLT uptake metrics are being used f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5746866e6f87887f1f97862883bc3065
https://research.vumc.nl/en/publications/c6e13ed1-6ce0-4fb0-a1aa-8f07a20bad01
https://research.vumc.nl/en/publications/c6e13ed1-6ce0-4fb0-a1aa-8f07a20bad01
Publikováno v:
Journal of Nuclear Medicine; Oct2020, Vol. 61 Issue 10, p1034-1037, 4p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Oncologist; Jun2008, Vol. 13 Issue 6, p631-644, 14p
Publikováno v:
Journal of Thoracic Oncology; 2007 Supplement 4, Vol. 2, pS187-S188, 2p
Autor:
van der Wel JWT; Department of Thoracic Oncology, Netherlands Cancer Institute, The Netherlands., Boelens MC; Department of Pathology, Netherlands Cancer Institute, The Netherlands., Jebbink M; Department of Thoracic Oncology, Netherlands Cancer Institute, The Netherlands., Smulders SA; Department of Pulmonary Diseases, Jeroen Bosch Hospital, The Netherlands., Maas KW; Department of Thoracic Oncology, Netherlands Cancer Institute, The Netherlands., Luitse MJA; Department of Neuro-oncology, Netherlands Cancer Institute, The Netherlands., Compter A; Department of Neuro-oncology, Netherlands Cancer Institute, The Netherlands., Boltjes RPB; Department of Neuro-oncology, Netherlands Cancer Institute, The Netherlands., Sol N; Department of Neuro-oncology, Netherlands Cancer Institute, The Netherlands., Monkhorst K; Department of Pathology, Netherlands Cancer Institute, The Netherlands.; Department of Pulmonary Diseases, Haaglanden Medical Center, The Netherlands., van den Broek D; Department of Laboratory Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands., Smit EF; Department of Thoracic Oncology, Netherlands Cancer Institute, The Netherlands.; Department of Pulmonary Diseases, Leiden University Medical Center, The Netherlands., de Langen AJ; Department of Thoracic Oncology, Netherlands Cancer Institute, The Netherlands., Brandsma D; Department of Thoracic Oncology, Netherlands Cancer Institute, The Netherlands.; Department of Neuro-oncology, Netherlands Cancer Institute, The Netherlands.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2024 Aug 07. Date of Electronic Publication: 2024 Aug 07.
Autor:
Paz-Ares L; Department of Medical Oncology, Hospital Universitario 12 de Octubre, CNIO-H12o Lung Cancer Unit, Complutense University and Ciberonc, Madrid, Spain. Electronic address: lpazaresr@seom.org., Mehta B; Amgen, Thousand Oaks, CA, USA., Wang Y; Amgen, Thousand Oaks, CA, USA., Waterhouse D; Oncology Hematology Care, Cincinnati, OH, USA., de Langen AJ; Netherlands Cancer Institute, Amsterdam, Netherlands.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2024 Aug; Vol. 25 (8), pp. e334.
Autor:
Hoog CJPO'; Department of Pharmacy, Radboud University Medical Center, Nijmegen, Netherlands., Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands., Maliepaard M; Department of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, Netherlands; Dutch Medicines Evaluation Board (CBG-MEB), Utrecht, Netherlands., Bol K; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands., de Langen AJ; Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands., van de Donk NWCJ; Department of Hematology, Amsterdam University Medical Center, location Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands., Janssen JJWM; Department of Hematology, Radboud University Medical Center, Nijmegen, Netherlands., Minnema MC; Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands., van Erp NP; Department of Pharmacy, Radboud University Medical Center, Nijmegen, Netherlands. Electronic address: nielka.vanerp@radboudumc.nl., Boerrigter E; Department of Pharmacy, Radboud University Medical Center, Nijmegen, Netherlands.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2024 Aug; Vol. 25 (8), pp. e340-e351.
Autor:
Miedema IHC; Department of Medical Oncology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands.; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, The Netherlands., Pouw JEE; Department of Medical Oncology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands.; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, The Netherlands., Kwakman A; Department of Medical Oncology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands.; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, The Netherlands., Zwezerijnen GJC; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands., Huisman MC; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands., Timmer FEF; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands., van de Ven R; Otolaryngology / Head and Neck Surgery, Amsterdam UMC - Locatie VUMC, Amsterdam, The Netherlands.; Cancer Biology and Immunology, Cancer Centre Amsterdam, Amsterdam, The Netherlands., de Gruijl TD; Department of Medical Oncology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands.; Cancer Biology and Immunology, Cancer Centre Amsterdam, Amsterdam, The Netherlands., Hospers GAP; Medical Oncology, University Medical Centre Groningen, Groningen, The Netherlands., de Langen AJ; NKI, Amsterdam, The Netherlands., Menke-van der Houven van Oordt CW; Department of Medical Oncology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands c.menke@amsterdamumc.nl.; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Jun 17; Vol. 12 (6). Date of Electronic Publication: 2024 Jun 17.